02.09.2022
Prevention
$1,693,379.00
36 months
Very Early Onset Inflammatory Bowel Disease (VEOIBD): Precision Molecular Diagnoses to Targeted Therapies-Toronto Studies
This grant will continue work to develop and refine clinical guidelines based on the findings from detailed functional experiments and high-throughput drug screening to identify novel personalized treatments for young children and infants with VEOIBD who are refractory to standard medications.